Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
Nicoletto MO, Tumolo S, Talamini R, Salvagno L, Franceschi S, Visonà E, Marin G, Angelini F, Brigato G, Scarabelli C, Carbone A, Cecchetto A, Prosperi A, Rosabian A, Giusto M, Cima GP, Morassut S, Nascimben O, Vinante O, Fiorentino MV. Nicoletto MO, et al. J Clin Oncol. 1997 Mar;15(3):994-9. doi: 10.1200/JCO.1997.15.3.994. J Clin Oncol. 1997. PMID: 9060538 Clinical Trial.
Experience with intraperitoneal alpha-2a interferon.
Nicoletto MO, Fiorentino MV, Vinante O, Prosperi A, Tredese F, Tumolo S, Cima GP, Monfardini S. Nicoletto MO, et al. Oncology. 1992;49(6):467-73. doi: 10.1159/000227094. Oncology. 1992. PMID: 1465286
Continuous mitoxantrone infusion in pretreated epithelial ovarian cancer.
Nicoletto MO, Padrini R, Koussis H, Rosabian A, Aversa S, Endrizzi L, Azzoni P, Palumbo M, Fiorentino MV. Nicoletto MO, et al. Cancer Chemother Pharmacol. 1995;35(6):506-10. doi: 10.1007/BF00686836. Cancer Chemother Pharmacol. 1995. PMID: 7882459 Clinical Trial.
Elderly ovarian cancer: treatment with mitoxantrone-carboplatin.
Nicoletto MO, Artioli G, Donach M, Sileni VC, Monfardini S, Talamini R, Veronesi A, Ferrazzi E, Tumolo S, Visonà E, Amichetti M, Endrizzi L, Salvagno L, Prosperi A, Azzoni P. Nicoletto MO, et al. Gynecol Oncol. 2001 Feb;80(2):221-6. doi: 10.1006/gyno.2000.6017. Gynecol Oncol. 2001. PMID: 11161863 Clinical Trial.
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
Paccagnella A, Oniga F, Bearz A, Favaretto A, Clerici M, Barbieri F, Riccardi A, Chella A, Tirelli U, Ceresoli G, Tumolo S, Ridolfi R, Biason R, Nicoletto MO, Belloni P, Veglia F, Ghi MG. Paccagnella A, et al. Among authors: nicoletto mo. J Clin Oncol. 2006 Feb 1;24(4):681-7. doi: 10.1200/JCO.2005.03.2722. J Clin Oncol. 2006. PMID: 16446341 Clinical Trial.
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer.
Nicoletto MO, Tumolo S, Sorio R, Cima G, Endrizzi L, Nascimben O, Vinante O, Artioli G, Donach M, Cartei G; Goccne Group (Gruppo Oncologico Cooperativo Clinico Nord-est), Padua, Italy. Nicoletto MO, et al. Int J Gynecol Cancer. 2007 Sep-Oct;17(5):986-92. doi: 10.1111/j.1525-1438.2007.00862.x. Epub 2007 Feb 19. Int J Gynecol Cancer. 2007. PMID: 17316364 Clinical Trial.
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium. du Bois A, et al. Among authors: nicoletto mo. Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16. Lancet Oncol. 2016. PMID: 26590673 Free article. Clinical Trial.
52 results